Moreover, CACNA2D1, which has been detected in human genome-wide association data as a candidate gene for depression65 and bipolar disorder66, has been suggested to be a potential target for depression treatment and rapid antidepressant effects67. Here, CACNA2D1 is linked to depressive symptom measurement.